Analysts have been eager to weigh in on the Healthcare sector with new ratings on RegenXBio (RGNX – Research Report) and Avidity Biosciences (RNA – Research Report). RegenXBio (RGNX) Wedbush analyst Andreas Argyrides reiterated a Hold rating on RegenXBio today and set a price target of $28.00. The company's shares closed last Monday at $24.17. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-regenxbio-rgnx-and-avidity-biosciences-rna?utm_source=advfn.com&utm_medium=referral
REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more REGENXBIO Charts.
REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more REGENXBIO Charts.